Peter Vozzo | Investor Relations |
Jerome Jabbour | Chief Executive Officer |
Keith Kucinski | Chief Financial Officer |
Terry Ferguson | Chief Medical Officer |
Terry Matkovits | Chief Development Officer |
Raphael Mannino | Chief Scientific Officer |
Robert Hazlett | BTIG |
Greg Fraser | Truist |
Greetings and welcome to Matinas BioPharma's Third Quarter 2021 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Peter Vozzo, Investor Relations representative for Matinas BioPharma.